Delivery Order SPE2DB22D1103-SPE2DB24FTRF6

Award Date 9/10/24
Potential Completion Date 9/11/24
Potential Value $28K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of OTEZLA 30 MG TABLET 60S, a medication, with a ceiling value of $2,618.99 and a performance period ending on May 20, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the prime...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of OTEZLA 30 mg tablets. The contract has a ceiling value of $40,332.44 and an ultimate completion date of September 30, 2024. This delivery order falls under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for the provision of a comprehensive range of...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, Corporate Office Division, a major pharmaceutical distributor. The contract, valued at $13,353.55, is for the delivery of 4565598895 OTEZLA 30 MG TABLET 60S, with a completion date of August 28, 2024. It is a firm fixed-price contract under an existing Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA, valued up to $999,999,999 through December 2025, for the supply of a...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of OTEZLA 30 mg tablets, a prescription medication. The award has a ceiling value of $11,404.34 and a period of performance through April 30, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that AmerisourceBergen holds...
This is a $6,702.80 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of OTEZLA 30 MG TABLET 60S, a pharmaceutical product, with a period of performance through December 18, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of OTEZLA 30 MG TAB 60S, a pharmaceutical product. The contract has a Firm Fixed Price pricing type and a ceiling value of $20,019.73. It is not designated with any set-aside requirements, indicating open competition. The contract is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract, valued at $25,159.21, is for the delivery of OTEZLA 30 MG TABLET 60S, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of May 29, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that Amerisourcebergen Drug Corp holds...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for OTEZLA 30 MG TABLET 60S. The contract has a ceiling value of $19,322.88 and runs through January 2, 2025. The contract is a Firm Fixed Price Delivery Order with no set-aside requirements, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of OTEZLA 30 MG TABLET 60S. The contract has a ceiling value of $15,397.10 and is a firm fixed price delivery order contract with an ultimate completion date of October 10, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of OTEZLA 30 MG TABLET 60S. The contract has a ceiling value of $4,278.97 and is a firm fixed price delivery order, without a set-aside designation. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global...
  • SPE2DB22D1103
    Indefinite Delivery Contract
  • SPE2DB22D1103-SPE2DB24FTRF6
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide OTEZLA 30 MG TABLET 60S. The contract has a ceiling value of $27,980.55 and a completion date of September 11, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999, for delivering a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract is a firm fixed-price arrangement and does not have a set-aside designation. AmerisourceBergen, as the prime contractor, will be responsible for supplying the OTEZLA medication to meet the government's requirement.

Generated 12/10/24, 2:37 PM